<DOC>
	<DOC>NCT00000322</DOC>
	<brief_summary>The purpose of this study is to evaluate efficacy of tyrosine as a treatment for methamphetamine dependence in an outpatient treatment setting providing group psychosocial interventions. Examine effect of tyrosine on abstinence, retention in treatment, and craving."</brief_summary>
	<brief_title>Tyrosine for Methamphetamine Dependence - 1</brief_title>
	<detailed_description>Evaluate efficacy of tyrosine as a treatment for methamphetamine dependence in an outpatient treatment setting providing group psychosocial interventions. Examine effect of tyrosine on abstinence, retention in treatment and craving.</detailed_description>
	<mesh_term>Amphetamine-Related Disorders</mesh_term>
	<mesh_term>Methamphetamine</mesh_term>
	<criteria>1865 years of age. Able to provide informed consent. Desire to reduce/eliminate methamphetamine use. Used within the past two weeks. Meet DSM criteria for methamphetamine dependence. No dependence (within the past 12 months) for other durgs except nicotine. No history or family history of tyrosine intolerance.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 1997</verification_date>
	<keyword>amphetamine dependence</keyword>
</DOC>